NYSE$CTEV

Claritev Corp · Q4 2025 earnings

Q4 2025 earnings · · After market close · Investor relations

Briefing

Claritev reported Q4 2025 revenue of $246.6M, a net loss of $80.6M, and adjusted EBITDA of $151.3M.

Claritev posted Q4 revenue of $246.6M (+6.2% YoY) with adjusted EBITDA of $151.3M (61.4% margin) and a net loss of $80.6M, improved from a $138.0M loss a year ago. FY2025 revenue grew 3.7% to $965.4M; adjusted EBITDA rose 4.5% to $602.6M. Q4 free cash flow was $36.4M. The board approved a $75M five-year share repurchase program (capped at $20M annually). FY2026 guidance calls for revenue of $980M–$1.0B, adjusted EBITDA of $605–$615M, capex of $160–$170M, and free cash flow of $0–$10M.

  • Q4 revenue $246.6M (+6.2%); adjusted EBITDA $151.3M.
  • Q4 net loss $80.6M; Q4 free cash flow $36.4M.
  • FY2025 revenue $965.4M; adjusted EBITDA $602.6M.
  • $75M share repurchase program approved for 2026–2030.

Headline financials

Total Revenue

$247M

Previous: $232M+6.2%
EPS (adj)

-$4.88

Previous: -$5.16+5.4%
Claim Charges Processed

$47.2B

No prior period
Potential Medical Cost Savings

$6.4B

No prior period
Net Income

-$80.6M

Previous: -$138M+41.6%
Operating Income

-$7.62M

Previous: -$1.39B+99.5%
Gross Profit

$176M

Previous: $66.2M+166.4%

Revenue & EPS history

Multiplan · Revenue · Quarterly

$247M

Q4 2025+6.2%vs Q4 2024
Beat estimate in 9 of 13 quarters(69%)
ActualEstimate

Forward guidance

FY2026 revenue $980M–$1.0B, adjusted EBITDA $605–$615M, capex $160–$170M, free cash flow $0–$10M, and tax rate 24–28%.

Tailwinds

  • Return to positive free cash flow expected in 2026.
  • Revenue growth outlook reflects durable core and expansion pipelines.
  • Share repurchase authorization supports capital returns.

Headwinds

  • Still reporting GAAP net losses despite EBITDA strength.
  • Heavy capex ($160–$170M) limits near-term FCF.
  • Low unrestricted cash ($16.8M) at quarter end.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

-6.5%

Avg return

Earnings day

-5.1%

Avg return

5 days after

-3.8%

Avg return

30 days after

36%

9 / 25 earnings

Positive

+20.8%

Q1 2021

Best reaction

-32.8%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-8.8%+7.7%-2.6%
Q4 2025-31.8%-42.0%-31.4%
Q3 2025+11.8%-5.4%-45.2%
Q1 2025+4.2%+7.5%+95.1%
Q4 2024-32.8%-28.1%-24.8%
Q3 2024-6.5%-3.4%-22.6%
Q2 2024-23.9%-10.2%-47.8%
Q1 2024+10.9%-1.5%-36.6%
Q4 2023-0.9%-13.4%-27.6%
Q3 2023-6.5%-9.7%-14.3%
Q2 2023-8.9%-14.0%-17.8%
Q1 2023-5.4%+21.0%+97.6%
Q4 2022-10.2%+10.0%+6.0%
Q3 2022-27.8%-18.3%-31.1%
Q2 2022-12.4%-13.4%-33.1%
Q1 2022+1.0%+18.4%+27.4%
Q4 2021-8.0%-18.9%-14.4%
Q3 2021+0.2%-11.0%-4.3%
Q2 2021-6.2%-10.5%-20.6%
Q1 2021+20.8%+27.0%+45.5%
Q2 2020+0.5%-0.2%+1.9%
Q4 2020-18.6%-20.3%-19.7%
Q3 2020-4.6%+0.7%+20.8%
Q1 2020+0.5%+0.7%+2.3%
Q4 2019+0.5%+0.7%+2.3%
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro